ABCG2 and leukemia: In the past years, the study of ABCG2 activity highlighted that beyond drug efflux, it contributes to changing leukemia cell biology, favoring the acquisition of stem cell properties, resulting in protection from drug toxicity and immune surveillance, and eventually preventing disease eradication also after stem cell transplantation.